期刊文献+

7852株临床分离病原菌株的分布特点及耐药性分析 被引量:6

Distribution and drug resistance of 7852 clinical isolated pathogenic bacterial strains
原文传递
导出
摘要 目的了解临床分离病原菌株的分布情况及主要病原菌的耐药特点。方法回顾性分析海南省人民医院2013年1~12月份分离出的7 852株病原菌,用DL-96微生物鉴定及药敏分析系统对分离菌进行鉴定和药敏分析,并对其分布特点和耐药性进行统计分析。结果 2013年共收集到非重复临床分离菌7 852株,其中革兰阴性菌65.9%(5 176/7 852),革兰阳性菌20.5%株(1 613/7 852),真菌13.5%(1 062/7 852)。构成比排名前5名的病原菌依次为铜绿假单胞菌(14.2%)、大肠埃希菌(13.0%)、肺炎克雷伯菌(8.3%)、鲍曼不动杆菌(7.0%)、金黄色葡萄球菌(6.8%)。凝固酶阴性葡萄球菌和耐甲氧西林金黄色葡萄球菌(MRSA)分别占4.3%和27.1%,革兰阳性菌对万古霉素均敏感,对利奈唑胺、替考拉宁敏感率较高,肠杆菌科细菌对亚胺培南和美罗培南、哌拉西林/他唑巴坦、头孢哌酮/舒巴坦、阿米卡星敏感性较高。大肠埃希菌、肺炎克雷伯菌ESBLs的检出率分别为40.4%、24.3%,ESBLs阳性菌株对大多数抗菌药物的耐药率高于非产ESBLs阴性的菌株。非发酵菌仅对粘菌素、多粘菌素B敏感性较高。鲍曼不动杆菌耐药率高于铜绿假单胞菌。结论临床分离的病原菌种类较多,且耐药性较高,及时监测病原菌变化及耐药趋势,提高临床标本送检率,指导临床合理使用抗生素至关重要。 Objective To investigate the distribution and drug resistance of main clinical pathogenic bacterial strains.Methods The 7 852 bacterial strains collected from Hainan People's Hospital in 2013 were retrospectively analyzed andidentified by DL-96.Drug sensitivity of these isolates was also performed. Results Totally 7 852 non- replicated strainswere collected,65.9%(5 176/7 852)of them were gram-negative,20.5%(1 613/7 852)were gram-positive and 13.5%(1 062/7 852)were fungi. The top five pathogens in proportion were Pseudomonas aeruginosa(14.2 %),Escherichia coli(13.0%),Klebsiella pneumoniae(8.3 %),Acinetobacter baumannii(7.0%)and Staphylococcus aureus(6.8%). Proportions ofcoagulase-negative Staphylococci and MRSA were 4.3% and 27.1% respectively. Gram-positive bacteria were all sensitive tovancomycin and the resistance rates were relatively high to linezolid and teicoplanin. Enterobacteria were relatively sensitiveto to imipenem and meropenem,piperacillin / tazobactam,cefoperazone / sulbactam,amikacin. The positive rates of ESBLs-producing Escherichia coli and Klebsiella pneumoniae were 40.4% and 24.3%,respectively.The resistance rate of ESBLs-producing strains was higher than that of non-ESBLs-producing strains to most antimicrobial drugs. The non-fermentativebacteria were only sensitive to colistin and polymyxin B.The drug resistance rate of Acinetobacter baumannii was higher thanthat of Pseudomonas aeruginosa.Conclusions There are many kinds of clinical isolates,and their drug resistance rates wererelatively high. Thus it is important to monitor the mutation and drug resistance of pathogens and improve the rational drug use.
出处 《中国热带医学》 CAS 2015年第5期605-608,614,共5页 China Tropical Medicine
关键词 耐药性 病原菌 细菌分布 Drug resistance Pathogens Bacteria distribution
  • 相关文献

参考文献8

  • 1胡付品,朱德妹,汪复,蒋晓飞,杨青,徐英春,张小江,孙自镛,陈中举,王传清,王爱敏,倪语星,孙景勇,俞云松,林洁,单斌,杜艳,徐元宏,沈继录,张泓,孔菁,卓超,苏丹虹,张朝霞,季萍,胡云建,艾效曼,黄文祥,贾蓓,魏莲花,吴玲.2011年中国CHINET细菌耐药性监测[J].中国感染与化疗杂志,2012,12(5):321-329. 被引量:526
  • 2Wolska K, szwedap.Genetic features of clinical Pseudomonas aerugi- nosa strains [J].Pol J Mierebiol, 2009,58(3) : 255-260.
  • 3Goolz TD.The forgolten Gram-negative bacilli: what genetic deter minants are telling as about the spread of antibiotic resistance [J]. Biochem pharmacol,2006,71 (7): 1073-1084.
  • 4陈科帆,吕晓菊.产NDM-1泛耐药肠杆菌科细菌研究进展[J].中国抗生素杂志,2013,38(4). 被引量:6
  • 5卓超,苏丹虹,倪语星,孙景勇,俞云松,杨青,孙自镛,简翠,汪复,朱德妹,胡付品,蒋晓飞,王传清,王爱敏,徐元宏,沈继录,徐英春,孙宏莉,张泓,李万华,单斌,杜艳,张朝霞,季萍,贾蓓,黄文祥,魏莲花,吴玲,胡云建,艾效曼.2009年中国CHINET大肠埃希菌和克雷伯菌属细菌耐药性监测[J].中国感染与化疗杂志,2010,10(6):430-435. 被引量:81
  • 6YangQW,WangH,SunHI,etal. Phenotypic andgenotypic character- ization of Enterobacteriaceae with decreased susceptibility tocarbapen- eros : results from largehospitalbased surveillance studies in China [J]. Antimicrob Agents Chemother, 2010,54(1) : 573-577.
  • 7刘锐,孙立娟,何成彦,郑岚.203株医院感染葡萄球菌的监测及耐药性分析[J].中国老年学杂志,2010,30(8):1145-1146. 被引量:2
  • 8许景峰,徐琳.抗菌药物耐药性的产生及遏制耐药性微生物的对策[J].中华医药杂志,2007,7(1):32-35.

二级参考文献42

  • 1杨长顺,刘文恩.MRSA耐药机制与分子生物学检测方法研究新进展[J].中华医院感染学杂志,2007,17(3):356-358. 被引量:73
  • 2Cohn LA,Middleton JR.A veterinary perspective on methicillin-resistant staphylococci[J].J Vet Emerg Crit Care (San Antonio),2101;20(1):31-45.
  • 3Corriere MD,Decker CF.MRSA:an evolving pathogen[J].Dis Mon,2008;26(6):7373-4.
  • 4Lodise TP,McKinnon PS.Clinical and economic impact of methicillin resistance in patients with Staphylococcus aureus bacteremia[J].Diagn Microbiol Infect Dis,2005;52(2):113-22.
  • 5Daniel A,Euler C,Collin M,et al.Synergism between a novel chimeric lysin and oxacillin protects against infection by methicillin-resistant staphylococcus aureus[J].Antimicrob Agents Chemother,2010;54(4):1603-12.
  • 6Moubareck C,Meziane-Cherif D,Courvalin P,et al.VanA-type Staphylococcus aureus strain VRSA-7 is partially dependent on ancomycin for growth[J].Antimicrob Agents Chemother,2009;53(9):3657-63.
  • 7Lee JH.Occurrence of methicillilr resistant staphylococcus aures strains from cattle andchicken and analyses of their mecA,mecR1 and mecI genes[J].Vet Microbiol,2006;114(1-2):155-9.
  • 8Arias CA, Murray BE. Antibiotic-resistant bugs in the 21st century-a clinical super-challenge[J]. N Engl J Med, 2009, 360(5) : 439-443.
  • 9Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing[S]. Tweenty-first in- formational supplement, 2011, M100-S21 Vol 31 No. 1.
  • 10Falagas ME, Giannopoulou KP, Kokolakis GN, et al. Fosfo- mycin: use beyond urinary tract and gastrointestinal infec tions[J]. Clin Infect Dis, 2008, 46(7): 1069-1077.

共引文献607

同被引文献52

  • 1Holohan C, Van SS, Longley DB, et al. Cancer drug resistance : an evolving paradigm [J]. Nature Reviews Cancer, 2013,13 (10) : 714-726.
  • 2Blair JM, Webber MA, Baylay AJ, et al. Molecular mechanisms of antibiotic resistance [ J ]. Nat Rev Microbiol, 2015,13 ( 1 ) : 42-51.
  • 3Lee tfY,Lee J,Lee YS,et al. Drug-resistance pattern of Mycobacterium tuberculosis strains from patients with pulmonary and extrapulmonary tuberculosis during 2006 to 2013 in a Korean tertiary medical center [J]. Korean J Intern Med,2015,30(3): 325-334.
  • 4Marzouk M, Ferjani A, Bouafia N, et al. Serotype distribution and antimicrobial resistance of invasive and noninvasive pneumococcal isolates in Tunisia[ J ]. Microb Drug Resist, 2015,21 ( 1 ) : 85-89.
  • 5Maddox TW, Clegg PD, Williams N J, et al. Antimicrobial resistance in bacteria from horses : Epidemiology of antimicrobial resistance [J]. Equine Vet J,2015,47(6) :756-765.
  • 6Wu Q, Yang Z, Nie Y, et al. Multi-drug resistance in cancer chemotherapeutics: mechanisms and lab approaches [J]. Cancer Lett,2014,347(2) : 159-166.
  • 7Holmes AH,Moore LS, Sundsfjord A, et al. Understanding the mechanisms and drivers of antimicrobial resistance [J ]. Lancet, 2016,387(10014) : 176-187.
  • 8Cohen NR, Lobritz MA, Collins JJ. Microbial persistence and the road to drug resistance [ J ]. Cell Host Microbe, 2013,13 (6) : 632- 642.
  • 9Afema JA,Mather AE,Sischo WM. Antimicrobial resistance profiles and diversity in Salmonella from humans and cattle, 2004-2011 [ J ]. Zoonoses Public Health, 2015,62 (7) : 506-517.
  • 10Knapp L,Amezquita A,McClure P,et al. Development of a protocol for predicting bacterial resistance to microbicides [ J ]. Appl Environ Microbiol, 2015,81 (8) : 2652-2659.

引证文献6

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部